Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and validation of novel therapeutic targets to facilitate the development of pain therapeutics.

Specifically, the focus of this FOA is on the basic science discovery of targets in the peripheral nervous system,

central nervous system, immune system or other tissues in the body that can be used to develop treatments that have minimal side effects and little to no abuse/addiction liability.

Research supported by this FOA must include rigorous validation studies to demonstrate the robustness of the target as a pain treatment target.

This will lower the risk of adopting the target in translational projects to develop small molecules, biologics, natural substances, or devices that interact with this target for new pain treatments.

Translational research to develop new medical devices are not the focus of this FOA.

Basic science studies of pain and related systems in the body are responsive to this FOA and are encouraged in the context of novel pain therapeutic target discovery.

This FOA is not specific for any one or group of pain conditions.

Projects to identify novel targets for acute pain, chronic pain, migraine, other headache disorders, osteoarthritis, diabetic neuropathy, chemotherapy-induced neuropathy, sickle-cell pain, post stroke pain, etc.

will be considered.

Projects to identify novel targets for a combination of chronic overlapping pain conditions or for specific pathological conditions will be considered.

Projects that seek to identify novel targets in specific populations such as women, children, older adults or other underrepresented groups will also be responsive to this FOA.
Related Programs

Medical Library Assistance

Department of Health and Human Services



Relevant Nonprofit Program Categories





Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-043.html

Additional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession.

Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-043.html

Contact:


Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Agency Email:


Date Posted:
2018-09-19

Application Due Date:


Archive Date:
2019-12-18



Social Entrepreneurship
Spotlight



Lauren Bush Lauren on FEED Projects and World Hunger


Lauren Bush Lauren on FEED Projects and World Hunger

The granddaughter of President George H.W. Bush, Lauren Bush Lauren, she launched the FEED Projects back in 2007 to address world hunger. FEED has contributed over 75 million meals worldwide through consumer goods sales like the “1” bag that feeds one child in school for an entire year for every bag sold.




Social Services Jobs in Iowa

  Foundation Related Jobs
  Education Jobs
  Fundraising & Development Jobs
  Substance Abuse Jobs
  Human Services Jobs





More Federal Domestic Assistance Programs


Missing Alzheimer"s Disease Patient Assistance Program | Office of Oceanic and Atmospheric Research (OAR) Joint and Cooperative Institutes | Financial Assistance for National Centers for Coastal Ocean Science | Disposal of Federal Surplus Real Property | State Public Health Approaches for Ensuring Quitline Capacity Funded in part by 2012 Prevention and  |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2019 Copyright Michael Saunders